MedTrace Logo

Hormonal Contraception and Risk of Chlamydia and Gonorrhea

NCT00091728 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2005-11-07

No results posted yet for this study

Summary

There are biological reasons to suspect that hormones may affect the risk of a woman becoming infected with a sexually transmitted disease. The evidence on this issue to date is mixed and previous studies have methodologic flaws making it difficult to draw conclusions about the results.

This study compares the risk of developing either Chlamydial or Gonorrheal infection among three groups of women: those using combined oral contraceptives (birth control pills); those using the injectable hormone (brand name Depo Provera); and those women using non-hormonal contraceptive methods.

Conditions

  • Chlamydia Infection
  • Neisseriaceae Infection

Interventions

DRUG

Depo Medroxyprogesterone acetate

DRUG

Combined oral contraceptives

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    lead NIH

Principal Investigators

  • Charles Morrison, Ph.D. · Family Health International, RTP, N.C.

  • Paul Blumenthal, M.D. · Maryland Planned Parenthood

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-09-30
Completion
2001-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00091728 on ClinicalTrials.gov